Stock Events

Stock Events

Agios Pharmaceuticals 

€22.6
46
-€0.6-2.59% Today

Statistics

Day High
23.2
Day Low
22.6
52W High
39.2
52W Low
19.7
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30JulExpected
Q4 2025
Q1 2026
Next
-1.65
-1.55
-1.46
-1.37
Expected EPS
-1.3711613409699999
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 8AP.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap4.98B
CRISPR Therapeutics is involved in gene editing, a technology that could compete with Agios's approach to treating genetic diseases.
Vertex Pharmaceuticals
VRTX
Mkt Cap107.83B
Vertex Pharmaceuticals develops treatments for cystic fibrosis and other serious diseases, competing in the rare disease market space.
Gilead Sciences
GILD
Mkt Cap163.4B
Gilead Sciences has a broad portfolio including oncology, competing in the cancer treatment space where Agios is also active.
AMGEN
AMGN
Mkt Cap178B
Amgen focuses on human therapeutics, including treatments for cancer and cardiovascular disease, areas Agios is exploring.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.45B
BioMarin Pharmaceutical specializes in enzyme replacement therapies for rare genetic disorders, directly competing with Agios's focus areas.
Sangamo Therapeutics
SGMO
Mkt Cap55.93M
Sangamo Therapeutics works on genomic medicine, including gene therapy, competing in the genetic disease treatment area.
Novartis
NVS
Mkt Cap279.67B
Novartis offers a wide range of healthcare solutions, including treatments for cancer and rare diseases, overlapping with Agios's market.
Alnylam Pharmaceuticals
ALNY
Mkt Cap39.51B
Alnylam Pharmaceuticals is a leader in RNAi therapeutics for rare genetic diseases, competing in the same niche as Agios.
Beam Therapeutics
BEAM
Mkt Cap3.15B
Beam Therapeutics specializes in precision genetic medicines using base editing, a novel approach that competes with Agios's strategies.

About

There is no Profile data available for 8AP.SG.
Show more...
CEO
Country
Germany
ISIN
US00847X1046

Listings

MU
DE
8AP.MU
STU
DE
8AP.STU
F
DE
8AP.F
BOATS
BOATS
AGIO.BOATS

0 Comments

Share your thoughts

FAQ

What is Agios Pharmaceuticals stock price today?▼
The current price of 8AP.STU is €22.6 EUR — it has decreased by -2.59% in the past 24 hours. Watch Agios Pharmaceuticals stock price performance more closely on the chart.
What is Agios Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Agios Pharmaceuticals stocks are traded under the ticker 8AP.STU.
Is Agios Pharmaceuticals stock price growing?▼
8AP.STU stock has fallen by -5.04% compared to the previous week, the month change is a -25.66% fall, over the last year Agios Pharmaceuticals has showed a -8.13% decrease.
When is the next Agios Pharmaceuticals earnings date?▼
Agios Pharmaceuticals is going to release the next earnings report on July 30, 2026.
What were Agios Pharmaceuticals earnings last quarter?▼
8AP.STU earnings for the last quarter are -1.45 EUR per share, whereas the estimation was -1.54 EUR resulting in a +6.29% surprise. The estimated earnings for the next quarter are N/A EUR per share.
In which sector is Agios Pharmaceuticals located?▼
Agios Pharmaceuticals operates in the Materials sector.
When did Agios Pharmaceuticals complete a stock split?▼
Agios Pharmaceuticals has not had any recent stock splits.